Analysis by Dr. Joseph Mercola<\/p>\n
<\/iframe><\/p>\n<p><!--more--><\/p>\n<div id=\"bcr_UpdPnlStory\">\n<div id=\"bcr_pnlStoryAtAGlance\" class=\"story-glance\" data-swiftype-name=\"saag\" data-swiftype-type=\"text\">\n<div class=\"story-highlights\">\n<h3 id=\"expanderHead\" data-jsid=\"expanderHead\">STORY AT-A-GLANCE<\/h3>\n<div id=\"expanderContent\" data-jsid=\"expanderContent\">\n<ul>\n<li><span id=\"bcr_rptStory_cslStory_0\">Paxlovid, which was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021, has become widely associated with rebound infection<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_1\">While the U.S. Centers for Disease Control and Prevention and Pfizer have tried to suggest that COVID rebound is spontaneous and not necessarily linked to Paxlovid, recent research found no rebound cases among COVID-19 patients who did not take Paxlovid<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_2\">People who take Paxlovid can also still transmit COVID-19 to others, even if they\u2019re asymptomatic<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_3\">A number of high-profile individuals have experienced COVID rebound after using Paxlovid, including \u201cThe Late Show\u201d host Stephen Colbert, comedian Jimmy Dore, Dr. Anthony Fauci, President Joe Biden, First Lady Jill Biden and CDC director Dr. Rochelle Walensky. Most were double-jabbed and double-boosted. Walensky actually had three boosters<\/span><\/li>\n<li><span id=\"bcr_rptStory_cslStory_4\">Emerging evidence also suggests SARS-CoV-2 can develop resistance to Paxlovid. Two separate studies cultured SARS-CoV-2 and exposed it to low levels of nirmatrelvir \u2014 the active antiviral ingredient in Paxlovid \u2014 which would kill some, but not all, of the virus. As a result, the virus became 20 times and 80 times less susceptible to the drug, respectively<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"bodytext\" class=\"bodytextdiv\" data-swiftype-name=\"postbody\" data-swiftype-type=\"text\">\n<p>So far, all of the drugs developed against COVID-19 have been disastrous in one way or another. Remdesivir, for example, which to this day is the primary COVID drug approved for use in U.S. hospitals,<sup><span id=\"edn1\" data-hash=\"#ednref1\">1<\/span><\/sup>\u00a0routinely causes severe organ damage<sup><span id=\"edn2\" data-hash=\"#ednref2\">2<\/span>,<span id=\"edn3\" data-hash=\"#ednref3\">3<\/span>,<span id=\"edn4\" data-hash=\"#ednref4\">4<\/span>,<span id=\"edn5\" data-hash=\"#ednref5\">5<\/span><\/sup>\u00a0and, often, death.<\/p>\n<p>Another notable one is Paxlovid, which was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.<sup><span id=\"edn6\" data-hash=\"#ednref6\">6<\/span><\/sup>\u00a0While not showing signs of being deadly like remdesivir, Paxlovid has become so widely associated with rebound infection that the U.S. Centers for Disease Control and Prevention has even issued a warning about it. According to the CDC\u2019s health advisory:<sup><span id=\"edn7\" data-hash=\"#ednref7\">7<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cRecent case reports document that some patients with normal immune response who have completed a 5-day course of Paxlovid for laboratory-confirmed infection and have recovered can experience recurrent illness 2 to 8 days later, including patients who have been vaccinated and\/or boosted.\u201d<\/em><\/p><\/blockquote>\n<h2>Asymptomatic Paxlovid Users Can Still Spread Infection<\/h2>\n<p>The CDC<sup><span id=\"edn8\" data-hash=\"#ednref8\">8<\/span><\/sup>\u00a0and Pfizer<sup><span id=\"edn9\" data-hash=\"#ednref9\">9<\/span><\/sup>\u00a0have suggested that sometimes COVID-19 naturally comes back after a person tests negative, implying that COVID-19 rebound is spontaneous and not necessarily linked to Paxlovid. However, research<sup><span id=\"edn10\" data-hash=\"#ednref10\">10<\/span><\/sup>\u00a0by Dr. Michael Charness of the Veterans Administration Medical Center in Boston refutes this notion.<\/p>\n<p>When Charness and colleagues analyzed 1,000 cases of COVID-19 diagnosed among members of the National Basketball Association \u2014 none of whom took Paxlovid \u2014 no cases of COVID-19 rebound were found.<sup><span id=\"edn11\" data-hash=\"#ednref11\">11<\/span><\/sup>\u00a0They also found that people who take Paxlovid can still transmit COVID-19 to others, even if they\u2019re asymptomatic. Charness told CNN:<sup><span id=\"edn12\" data-hash=\"#ednref12\">12<\/span><\/sup><\/p>\n<blockquote>\n<div class=\"MidProductAd\"><\/div>\n<p><em>“People who experience rebound are at risk of transmitting to other people, even though they’re outside what people accept as the usual window for being able to transmit.”<\/em><\/p><\/blockquote>\n<h2>Is Paxlovid-Induced Rebound Really Rare?<\/h2>\n<p>While Paxlovid-induced rebound of COVID is clearly widespread, health authorities insist the effect is \u201crare.\u201d<sup><span id=\"edn13\" data-hash=\"#ednref13\">13<\/span><\/sup>\u00a0Pfizer\u2019s clinical trial had a 1% to 2% rebound rate. White House COVID response coordinator, Dr. Ashish Jha, put the rebound rate at 5% in real-life settings.<\/p>\n<p>\u201cIf you look at Twitter, it feels like everybody has rebound,\u201d Jha said during a White House press conference in July 2022. \u201cBut it turns out there\u2019s actually clinical data.\u201d<sup><span id=\"edn14\" data-hash=\"#ednref14\">14<\/span><\/sup><\/p>\n<p>In one such study,<sup><span id=\"edn15\" data-hash=\"#ednref15\">15<\/span><\/sup>\u00a05.87% of the 13,600 patients experienced rebound of symptoms within a month of the treatment. Dr. Aditya Shah, an infectious disease specialist at the Mayo Clinic, thinks the rebound rate may be as high as 10%.<sup><span id=\"edn16\" data-hash=\"#ednref16\">16<\/span><\/sup><\/p>\n<p>But if those rebound statistics were actually true, how does one explain the fact that so many high-profile celebrities and government officials who have used it have ended up rebounding? Statistically, that seems rather incredible.<\/p>\n<h2>High-Profile Rebound Cases<\/h2>\n<div align=\"center\">\n<div class=\"twitter-tweet twitter-tweet-rendered\"><iframe id=\"twitter-widget-0\" class=\"\" title=\"Twitter Tweet\" src=\"https:\/\/platform.twitter.com\/embed\/Tweet.html?creatorScreenName=mercola&dnt=false&embedId=twitter-widget-0&features=eyJ0ZndfdGltZWxpbmVfbGlzdCI6eyJidWNrZXQiOlsibGlua3RyLmVlIiwidHIuZWUiLCJ0ZXJyYS5jb20uYnIiLCJ3d3cubGlua3RyLmVlIiwid3d3LnRyLmVlIiwid3d3LnRlcnJhLmNvbS5iciJdLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdGltZWxpbmVfMTIwMzQiOnsiYnVja2V0IjoidHJlYXRtZW50IiwidmVyc2lvbiI6bnVsbH0sInRmd190d2VldF9lZGl0X2JhY2tlbmQiOnsiYnVja2V0Ijoib24iLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3JlZnNyY19zZXNzaW9uIjp7ImJ1Y2tldCI6Im9uIiwidmVyc2lvbiI6bnVsbH0sInRmd19jaGluX3BpbGxzXzE0NzQxIjp7ImJ1Y2tldCI6ImNvbG9yX2ljb25zIiwidmVyc2lvbiI6bnVsbH0sInRmd190d2VldF9yZXN1bHRfbWlncmF0aW9uXzEzOTc5Ijp7ImJ1Y2tldCI6InR3ZWV0X3Jlc3VsdCIsInZlcnNpb24iOm51bGx9LCJ0Zndfc2Vuc2l0aXZlX21lZGlhX2ludGVyc3RpdGlhbF8xMzk2MyI6eyJidWNrZXQiOiJpbnRlcnN0aXRpYWwiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2V4cGVyaW1lbnRzX2Nvb2tpZV9leHBpcmF0aW9uIjp7ImJ1Y2tldCI6MTIwOTYwMCwidmVyc2lvbiI6bnVsbH0sInRmd19kdXBsaWNhdGVfc2NyaWJlc190b19zZXR0aW5ncyI6eyJidWNrZXQiOiJvbiIsInZlcnNpb24iOm51bGx9LCJ0ZndfdmlkZW9faGxzX2R5bmFtaWNfbWFuaWZlc3RzXzE1MDgyIjp7ImJ1Y2tldCI6InRydWVfYml0cmF0ZSIsInZlcnNpb24iOm51bGx9LCJ0Zndfc2hvd19ibHVlX3ZlcmlmaWVkX2JhZGdlIjp7ImJ1Y2tldCI6Im9uIiwidmVyc2lvbiI6bnVsbH0sInRmd190d2VldF9lZGl0X2Zyb250ZW5kIjp7ImJ1Y2tldCI6Im9uIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1550193774445436929&lang=en&origin=https%3A%2F%2Farticles.mercola.com%2Fsites%2Farticles%2Farchive%2F2022%2F11%2F10%2Fpaxlovid-fraud.aspx&sessionId=037913e0320ef881f0ba341d7a93cdea80d3012d&siteScreenName=mercola&theme=light&widgetsVersion=a3525f077c700%3A1667415560940&width=550px\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\" data-tweet-id=\"1550193774445436929\" data-mce-fragment=\"1\"><\/iframe><\/div>\n<\/div>\n<p>For example, in April 2022, the fully jabbed and boosted \u201cLate Show\u201d host Stephen Colbert got COVID, took Paxlovid and recovered, only to suffer a rebound a week later. Tweeting about his experience, Colbert referred to it as the \u201cWORST. SEQUEL. EVER.\u201d<sup><span id=\"edn17\" data-hash=\"#ednref17\">17<\/span><\/sup>\u00a0Comedian Jimmy Dore also experienced COVID-19 rebound after taking Paxlovid.<sup><span id=\"edn18\" data-hash=\"#ednref18\">18<\/span><\/sup><\/p>\n<p>Dr. Anthony Fauci got COVID in June 2022 \u2014 again despite being double-jabbed and double-boosted \u2014 and proudly shared that\u00a0<a href=\"https:\/\/takecontrol.substack.com\/p\/fauci-covid-19-rebound-after-taking-paxlovid\" target=\"_blank\" rel=\"noopener\">he took Paxlovid<\/a>. Immediately after the five-day treatment, he tested negative for SARS-CoV-2. Alas, three days after that, he not only tested positive again but all the symptoms of infection also returned, and they were more severe than the first time around.<sup><span id=\"edn19\" data-hash=\"#ednref19\">19<\/span>,<span id=\"edn20\" data-hash=\"#ednref20\">20<\/span><\/sup><\/p>\n<p>Fauci described his rebound in an interview: \u201cOver the next day or so I started to feel really poorly, much worse than in the first go around. I went back on Paxlovid, and right now I am on my fourth day of a five-day course of my second course of Paxlovid. Fortunately, I feel reasonably good. I mean, I’m not completely without symptoms, but I certainly don’t feel acutely ill.”<sup><span id=\"edn21\" data-hash=\"#ednref21\">21<\/span><\/sup><\/p>\n<p>At the end of July 2022, it was President Joe Biden\u2019s turn to announce he had COVID, despite being double-jabbed and double-boosted \u2014 something Biden had previously insisted could not happen (see video above). He too took Paxlovid and, like Fauci, ended up rebounding around Day 3, just as I predicted on Twitter.<sup><span id=\"edn22\" data-hash=\"#ednref22\">22<\/span><\/sup>\u00a0Unlike Fauci, however, he reportedly didn\u2019t have any symptoms.<sup><span id=\"edn23\" data-hash=\"#ednref23\">23<\/span><\/sup><\/p>\n<p>In mid-August 2022, the double-jabbed, double-boosted First Lady, Jill Biden, came down with COVID,<sup><span id=\"edn24\" data-hash=\"#ednref24\">24<\/span><\/sup>\u00a0took Paxlovid and, like clockwork, rebounded a few days after finishing the treatment and initially testing negative.<sup><span id=\"edn25\" data-hash=\"#ednref25\">25<\/span><\/sup><\/p>\n<p>Toward the end of October 2022, double-jabbed and TRIPLE-boosted Dr. Rochelle Walensky, director for the U.S. Centers for Disease Control and Prevention, got COVID. She\u2019d received her fifth shot \u2014 the latest bivalent booster that has only been tested on mice \u2014 on September 22.<sup><span id=\"edn26\" data-hash=\"#ednref26\">26<\/span><\/sup><\/p>\n<p>Exactly one month later, she tested positive and reported mild symptoms.<sup><span id=\"edn27\" data-hash=\"#ednref27\">27<\/span>,<span id=\"edn28\" data-hash=\"#ednref28\">28<\/span><\/sup>\u00a0I think that makes the \u201cnew and improved\u201d bivalent booster the shortest-acting shot so far. Anyway, Paxlovid to the rescue once again. And once again, it caused rebound. After initially testing negative after the treatment, she tested positive a couple of days later as symptoms returned.<sup><span id=\"edn29\" data-hash=\"#ednref29\">29<\/span><\/sup><\/p>\n<div class=\"productad\"><\/div>\n<h2>Government Researchers Investigating Rebound Effect<\/h2>\n<p>At the end of April 2022, Bloomberg described the post-Paxlovid rebound of David Ho, a virologist at the Aaron Diamond AIDS Research Center at Columbia University:<sup><span id=\"edn30\" data-hash=\"#ednref30\">30<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cHo said he came down with COVID on April 6 … His doctor prescribed Paxlovid, and within days of taking it, his symptoms dissipated and tests turned negative. But 10 days after first getting sick, the symptoms returned and his tests turned positive for another two days.<\/em><\/p><\/blockquote>\n<blockquote><p><em>Ho said he sequenced his own virus and found that both infections were from the same strain, confirming that the virus had not mutated and become resistant to Paxlovid. A second family member who also got sick around the same time also had post-Paxlovid rebound in symptoms and virus, Ho says.<\/em><\/p><\/blockquote>\n<blockquote><p><em>\u2018It surprised the heck out of me,\u2019 he said. \u2018Up until that point I had not heard of such cases elsewhere.\u2019 While the reasons for the rebound are still unclear, Ho theorizes that it may occur when a small proportion of virus-infected cells may remain viable and resume pumping out viral progeny once treatment stops.\u201d<\/em><\/p><\/blockquote>\n<p>Clinical Director of the Division of Infectious Diseases at Brigham and Women\u2019s Hospital, Dr. Paul Sax, told Bloomberg:<sup><span id=\"edn31\" data-hash=\"#ednref31\">31<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cProviders who are going to be prescribing this should be aware that this phenomenon occurs, and if people have symptoms worsening after Paxlovid, it\u2019s probably still COVID. The big problem is that when this drug was released, this information wasn\u2019t included [on the label].\u201d<\/em><\/p><\/blockquote>\n<p>Research published in Clinical Infectious Diseases<sup><span id=\"edn32\" data-hash=\"#ednref32\">32<\/span>,<span id=\"edn33\" data-hash=\"#ednref33\">33<\/span><\/sup>\u00a0looked into why Paxlovid may be leading to rebound symptoms and suggests it could be the result of insufficient exposure to the drug. Possibly, the drug is metabolized more rapidly in some individuals. Alternatively, perhaps the drug needs to be administered for a longer period of time.<\/p>\n<h2>Is SARS-CoV-2 Becoming Resistant to Paxlovid?<\/h2>\n<p>Emerging evidence also suggests SARS-CoV-2 can develop resistance to Paxlovid if the drug doesn\u2019t eradicate all of the virus the first time around. Two separate studies cultured SARS-CoV-2 in a lab and exposed it to low levels of nirmatrelvir \u2014 the active antiviral ingredient in Paxlovid \u2014 which would kill some, but not all, of the virus.<\/p>\n<p>\u201cSuch tests are meant to simulate what might happen in an infected person who doesn\u2019t take the whole regimen of the drug or an immunocompromised patient who has trouble clearing the virus,\u201d Science reported.<sup><span id=\"edn34\" data-hash=\"#ednref34\">34<\/span><\/sup><\/p>\n<p>One of the studies revealed that SARS-CoV-2 developed three mutations after 12 rounds of nirmatrelvir treatment \u2014 \u201cat positions 50, 166 and 167 in the string of amino acids that make up MPRO.\u201d<sup><span id=\"edn35\" data-hash=\"#ednref35\">35<\/span><\/sup>\u00a0The mutations amounted to a 20-fold reduction in the virus\u2019 susceptibility to nirmatrelvir.<sup><span id=\"edn36\" data-hash=\"#ednref36\">36<\/span><\/sup><\/p>\n<p>The other study<sup><span id=\"edn37\" data-hash=\"#ednref37\">37<\/span><\/sup>\u00a0also found mutations at positions 50 and 166, revealing that when they occurred together, SARS-CoV-2 became 80 times less susceptible to nirmatrelvir. According to the authors:<sup><span id=\"edn38\" data-hash=\"#ednref38\">38<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cReverse genetic studies in a homologous infectious cell culture system revealed up to 80-fold resistance conferred by the combination of substitutions L50F and E166V. Resistant variants had high fitness increasing the likelihood of occurrence and spread of resistance.\u201d<\/em><\/p><\/blockquote>\n<p>It\u2019s still unknown what might happen when two courses of Paxlovid are taken in quick succession to treat COVID-19 rebound \u2014 as occurred with Fauci. It’s possible that ever-mutating COVID-19 variants could be created.<\/p>\n<p>Other antivirals on the market to treat COVID-19 have also led to concerns about drug resistance. Molnupiravir (sold under the brand name Lagevrio), approved by the FDA for emergency use in high-risk patients with mild to moderate COVID symptoms, has been shown to supercharge the rate at which the virus mutates inside the patient, resulting in newer and more drug resistant variants.<sup><span id=\"edn39\" data-hash=\"#ednref39\">39<\/span><\/sup><\/p>\n<h2>Pfizer Gets Rich on Fraudulent Drugs<\/h2>\n<div class=\"video-rwd has-figcaption\">\n<figure class=\"op-interactive aspect-ratio\"><iframe loading=\"lazy\" id=\"iFrameResizer0\" class=\" mlazyloaded\" src=\"https:\/\/www.bitchute.com\/embed\/b2zoeEW2Koiw\/\" width=\"640\" height=\"360\" frameborder=\"0\" scrolling=\"no\" data-mlazyload-src=\"https:\/\/www.bitchute.com\/embed\/b2zoeEW2Koiw\/\" data-mce-fragment=\"1\"><\/iframe><figcaption class=\"op-large op-center\"><a href=\"https:\/\/www.bitchute.com\/video\/b2zoeEW2Koiw\/\" target=\"_blank\" rel=\"noopener\">Video Link<\/a><\/figcaption><\/figure>\n<\/div>\n<p>Pfizer\u2019s revenue is expected to reach $101.3 billion in 2022,<sup><span id=\"edn40\" data-hash=\"#ednref40\">40<\/span><\/sup>\u00a0thanks to the COVID jab and Paxlovid ($10 billion from Paxlovid alone) \u2014 both of which are frauds. Neither of them actually work as advertised, and both can make matters worse. In the case of Pfizer\u2019s COVID-19 shot, you can still get the disease once you\u2019ve been injected and boosted, and may still transmit the disease to others as well.<\/p>\n<p>Then, when the shots don\u2019t work to prevent infection \u2014 and we\u2019ve now seen even five doses won\u2019t prevent infection \u2014 Pfizer makes even more money by selling Paxlovid, which in many cases causes rebound! There can be only one reason for why the FDA has not withdrawn both of these drugs, and that is because they\u2019re actually working for Pfizer.<\/p>\n<aside class=\"takeaway tamiddle\">Immunocompromised patients \u2018may carry this virus for a very, very long time, and we see that area as a real new opportunity growth area for Paxlovid to do very well, where you may need to take multiple courses.\u2019 ~ Dr. Mikael Dolsten, chief scientist and president of Worldwide Research and Development at Pfizer<\/p>\n<\/aside>\n<p>Pfizer itself doesn\u2019t view COVID rebound after Paxlovid treatment as a failure; they see it as a successful venture because the more courses needed, the more money they make. As reported by the Kaiser Family Foundation (KFF) in early July 2022:<sup><span id=\"edn41\" data-hash=\"#ednref41\">41<\/span><\/sup><\/p>\n<blockquote><p><em>\u201cDuring a recent investor call, a Pfizer official could spin the recent reports that the virus can hide from Paxlovid into good news, predicting that, as with the vaccine, patients may need multiple courses.<\/em><\/p><\/blockquote>\n<blockquote><p><em>Immunocompromised patients \u2018may carry this virus for a very, very long time,\u2019 Dr. Mikael Dolsten [chief scientist and President of Worldwide Research and Development at Pfizer<sup><span id=\"edn42\" data-hash=\"#ednref42\">42<\/span><\/sup>] said in the investor call. \u2018And we see that area as a real new opportunity growth area for Paxlovid to do very well, where you may need to take multiple courses.\u2019\u201d<\/em><\/p><\/blockquote>\n<h2>FDA and CDC Are Extensions of the Drug Industry<\/h2>\n<p>Pushing a drug that causes COVID rebound does not appear to be in the best interest of public health. Paxlovid is a fraud and should be taken off the market. The fact that the FDA and CDC have focused on Paxlovid, remdesivir and molnupiravir to the exclusion of all others, including older drugs with high rates of effectiveness and superior safety profiles, sends a very disturbing message.<\/p>\n<p>They\u2019ve basically become extensions of the drug industry and have abandoned their original purpose, which is to protect public health \u2014 by ensuring the safety and efficacy of drugs, in the case of the FDA,<sup><span id=\"edn43\" data-hash=\"#ednref43\">43<\/span><\/sup>\u00a0and by conducting critical science and data analysis in the case of the CDC.<sup><span id=\"edn44\" data-hash=\"#ednref44\">44<\/span><\/sup><\/p>\n<p>Instead, they seem to be doing everything they can to protect Big Pharma profits, even if it costs you your life. Remdesivir, for example, costs between $2,340 and $3,120 depending on your insurance.<sup><span id=\"edn45\" data-hash=\"#ednref45\">45<\/span><\/sup>\u00a0Ivermectin, meanwhile \u2014 which has been very effective against COVID and shown to outperform at least 10 other drugs, including Paxlovid<sup><span id=\"edn46\" data-hash=\"#ednref46\">46<\/span><\/sup>\u00a0\u2014 costs between $48<sup><span id=\"edn47\" data-hash=\"#ednref47\">47<\/span><\/sup>\u00a0and $94<sup><span id=\"edn48\" data-hash=\"#ednref48\">48<\/span><\/sup>\u00a0for 20 pills depending on your location. The average cost is said to be about $58 per treatment.<sup><span id=\"edn49\" data-hash=\"#ednref49\">49<\/span><\/sup><\/p>\n<p>Paxlovid costs $529 per five-day course of treatment,<sup><span id=\"edn50\" data-hash=\"#ednref50\">50<\/span><\/sup>\u00a0and molnupiravir is around $700.<sup><span id=\"edn51\" data-hash=\"#ednref51\">51<\/span><\/sup>\u00a0While not quite as expensive as remdesivir, both are still nearly 10 times costlier than ivermectin, which is more effective. Imagine the billions of dollars we could have saved were it not for our health agencies being so compromised by industry.<\/p>\n<p>Since the FDA and CDC cannot be trusted, it\u2019s imperative to take responsibility for your own health. Do your own research and follow your own conscience and conviction. Remember, when it comes to COVID-19, early treatment is crucial, and effective protocols are readily available \u2014 just not from the FDA, CDC or even most hospitals.<\/p>\n<p>For a refresher, check out\u00a0<a href=\"https:\/\/takecontrol.substack.com\/p\/covid-19-highly-treatable\" target=\"_blank\" rel=\"noopener\">Dr. Pierre Kory\u2019s interview with Chris Martenson<\/a>. You can also find many other articles describing treatment protocols by\u00a0<a href=\"https:\/\/takecontrol.substack.com\/archive?sort=search&search=early%20treatment%20protocol\" target=\"_blank\" rel=\"noopener\">searching through my Substack archive<\/a>.<\/p>\n<\/div>\n<div id=\"bcr_divfootnote\" class=\"sources-references narrow-width\"><span id=\"refclone1\"><\/span><\/p>\n<h3 id=\"heading\" class=\"title link16\" data-jsid=\"sourcesReferencesBtn\">–\u00a0Sources and References<\/h3>\n<div id=\"contentrefsources\" class=\"contentrefsources\" data-jsid=\"sourcesReferences\">\n<div class=\"sources sourcesfoot\"><\/div>\n<div id=\"bcr_divReferences\" class=\"references\">\n<ul id=\"footnote-references2\">\n<li><sup><span id=\"ednref1\" data-hash=\"#edn1\"><span id=\"lblReferenceNo\">1<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19\" target=\"_blank\" rel=\"noopener\">FDA, October 22, 2020<\/a><\/li>\n<li><sup><span id=\"ednref2\" data-hash=\"#edn2\"><span id=\"lblReferenceNo\">2<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC7326458\/\" target=\"_blank\" rel=\"noopener\">International Journal of Infectious Diseases, 2020; doi: 10.1016\/j.ijid.2020.06.093<\/a><\/li>\n<li><sup><span id=\"ednref3\" data-hash=\"#edn3\"><span id=\"lblReferenceNo\">3<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2023184\" target=\"_blank\" rel=\"noopener\">New England Journal of Medicine, 2021;384:497<\/a><\/li>\n<li><sup><span id=\"ednref4\" data-hash=\"#edn4\"><span id=\"lblReferenceNo\">4<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.scientificfreedom.dk\/wp-content\/uploads\/2020\/06\/G%C3%B8tzsche-Remdesivir-against-coronavirus-hope-or-hype.pdf\" target=\"_blank\" rel=\"noopener\">Scientific Freedom, June 1, 2020<\/a><\/li>\n<li><sup><span id=\"ednref5\" data-hash=\"#edn5\"><span id=\"lblReferenceNo\">5<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)31022-9\/fulltext\" target=\"_blank\" rel=\"noopener\">The Lancet, 2020;395(10236):P1569<\/a><\/li>\n<li><sup><span id=\"ednref6\" data-hash=\"#edn6\"><span id=\"lblReferenceNo\">6<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19\" target=\"_blank\" rel=\"noopener\">U.S. FDA December 22, 2021<\/a><\/li>\n<li><sup><span id=\"ednref7\" data-hash=\"#edn7\"><span id=\"lblReferenceNo\">7,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref8\" data-hash=\"#edn8\"><span id=\"lblReferenceNo\">8<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/emergency.cdc.gov\/han\/2022\/han00467.asp\" target=\"_blank\" rel=\"noopener\">U.S. CDC, COVID-19 Rebound After Paxlovid Treatment May 24, 2022<\/a><\/li>\n<li><sup><span id=\"ednref9\" data-hash=\"#edn9\"><span id=\"lblReferenceNo\">9,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref11\" data-hash=\"#edn11\"><span id=\"lblReferenceNo\">11,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref12\" data-hash=\"#edn12\"><span id=\"lblReferenceNo\">12<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cnn.com\/2022\/05\/31\/health\/paxlovid-rebound-contagious-study-wellness\/index.html\" target=\"_blank\" rel=\"noopener\">CNN May 31, 2022<\/a><\/li>\n<li><sup><span id=\"ednref10\" data-hash=\"#edn10\"><span id=\"lblReferenceNo\">10<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2206449\" target=\"_blank\" rel=\"noopener\">NEJM September 15, 2022; 387: 1045-1047<\/a><\/li>\n<li><sup><span id=\"ednref13\" data-hash=\"#edn13\"><span id=\"lblReferenceNo\">13,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref14\" data-hash=\"#edn14\"><span id=\"lblReferenceNo\">14,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref16\" data-hash=\"#edn16\"><span id=\"lblReferenceNo\">16,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref19\" data-hash=\"#edn19\"><span id=\"lblReferenceNo\">19<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cnbc.com\/2022\/07\/27\/as-more-people-report-covid-rebounds-after-paxlovid-experts-insist-cases-are-rare.html\" target=\"_blank\" rel=\"noopener\">CNBC July 27, 2022<\/a><\/li>\n<li><sup><span id=\"ednref15\" data-hash=\"#edn15\"><span id=\"lblReferenceNo\">15<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2022.06.21.22276724v1\" target=\"_blank\" rel=\"noopener\">MedRxiv June 22, 2022<\/a><\/li>\n<li><sup><span id=\"ednref17\" data-hash=\"#edn17\"><span id=\"lblReferenceNo\">17<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.yahoo.com\/lifestyle\/stephen-colbert-suffers-covid-relapse-120220833.html\" target=\"_blank\" rel=\"noopener\">Yahoo! May 11, 2022<\/a><\/li>\n<li><sup><span id=\"ednref18\" data-hash=\"#edn18\"><span id=\"lblReferenceNo\">18<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.bitchute.com\/video\/b2zoeEW2Koiw\/\" target=\"_blank\" rel=\"noopener\">Bitchute Jimmy Dore Show August 2, 2022<\/a><\/li>\n<li><sup><span id=\"ednref20\" data-hash=\"#edn20\"><span id=\"lblReferenceNo\">20<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.forbes.com\/sites\/brucelee\/2022\/06\/30\/dr-fauci-takes-2nd-course-of-paxlovid-after-suffering-covid-19-rebound\/?sh=944b4f915d62\" target=\"_blank\" rel=\"noopener\">Forbes June 30, 2022<\/a><\/li>\n<li><sup><span id=\"ednref21\" data-hash=\"#edn21\"><span id=\"lblReferenceNo\">21<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cnn.com\/2022\/06\/30\/health\/covid-paxlovid-fauci-rebound\/index.html\" target=\"_blank\" rel=\"noopener\">CNN June 30, 2022<\/a><\/li>\n<li><sup><span id=\"ednref22\" data-hash=\"#edn22\"><span id=\"lblReferenceNo\">22<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/twitter.com\/mercola\/status\/1550193774445436929?s=20&t=v9zNBw7wj1NHDvaPpTkQPQ\" target=\"_blank\" rel=\"noopener\">Twitter Joseph Mercola July 21, 2022<\/a><\/li>\n<li><sup><span id=\"ednref23\" data-hash=\"#edn23\"><span id=\"lblReferenceNo\">23<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.politico.com\/news\/2022\/07\/30\/biden-covid-rebound-paxlovid-00048349\" target=\"_blank\" rel=\"noopener\">Politico July 30, 2022<\/a><\/li>\n<li><sup><span id=\"ednref24\" data-hash=\"#edn24\"><span id=\"lblReferenceNo\">24<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.politico.com\/news\/2022\/08\/16\/jill-biden-tests-positive-for-covid-00052133\" target=\"_blank\" rel=\"noopener\">Politico August 16, 2022<\/a><\/li>\n<li><sup><span id=\"ednref25\" data-hash=\"#edn25\"><span id=\"lblReferenceNo\">25<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cnn.com\/2022\/08\/29\/politics\/jill-biden-negative-covid\/index.html\" target=\"_blank\" rel=\"noopener\">CNN August 29, 2022<\/a><\/li>\n<li><sup><span id=\"ednref26\" data-hash=\"#edn26\"><span id=\"lblReferenceNo\">26<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/twitter.com\/ianmSC\/status\/1583861253675503616\" target=\"_blank\" rel=\"noopener\">Twitter Ian Miller October 22, 2022<\/a><\/li>\n<li><sup><span id=\"ednref27\" data-hash=\"#edn27\"><span id=\"lblReferenceNo\">27<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/worldfreedomalliance.org\/au\/news\/cdc-director-tests-positive-for-covid-19-despite-being-up-to-date-on-boosters\/\" target=\"_blank\" rel=\"noopener\">World Freedom Alliance October 23, 2022<\/a><\/li>\n<li><sup><span id=\"ednref28\" data-hash=\"#edn28\"><span id=\"lblReferenceNo\">28<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/nypost.com\/2022\/10\/22\/cdc-director-dr-rochelle-walensky-comes-down-with-covid-a-month-after-booster\/\" target=\"_blank\" rel=\"noopener\">NY Post October 22, 2022<\/a><\/li>\n<li><sup><span id=\"ednref29\" data-hash=\"#edn29\"><span id=\"lblReferenceNo\">29<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.msn.com\/en-us\/health\/medical\/cdc-director-tests-positive-for-covid-19-again-after-paxlovid-treatment\/ar-AA13AVcf\" target=\"_blank\" rel=\"noopener\">MSN October 31, 2022<\/a><\/li>\n<li><sup><span id=\"ednref30\" data-hash=\"#edn30\"><span id=\"lblReferenceNo\">30,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref31\" data-hash=\"#edn31\"><span id=\"lblReferenceNo\">31<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/archive.ph\/XVMDg\" target=\"_blank\" rel=\"noopener\">Bloomberg April 29, 2022 (Archived)<\/a><\/li>\n<li><sup><span id=\"ednref32\" data-hash=\"#edn32\"><span id=\"lblReferenceNo\">32<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciac496\/6611663?login=false\" target=\"_blank\" rel=\"noopener\">Clinical Infectious Diseases June 20, 2022<\/a><\/li>\n<li><sup><span id=\"ednref33\" data-hash=\"#edn33\"><span id=\"lblReferenceNo\">33<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/health.ucsd.edu\/news\/releases\/Pages\/2022-06-21-covid-19-rebound-after-taking-paxlovid-likely-due-to-insufficient-drug-exposure.aspx\" target=\"_blank\" rel=\"noopener\">UC San Diego Health June 21, 2022<\/a><\/li>\n<li><sup><span id=\"ednref34\" data-hash=\"#edn34\"><span id=\"lblReferenceNo\">34,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref36\" data-hash=\"#edn36\"><span id=\"lblReferenceNo\">36<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.science.org\/content\/article\/bad-news-paxlovid-coronavirus-can-find-multiple-ways-evade-covid-19-drug\" target=\"_blank\" rel=\"noopener\">Science June 29, 2022<\/a><\/li>\n<li><sup><span id=\"ednref35\" data-hash=\"#edn35\"><span id=\"lblReferenceNo\">35,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref37\" data-hash=\"#edn37\"><span id=\"lblReferenceNo\">37,<\/span><\/span><\/sup>\u00a0<sup><span id=\"ednref38\" data-hash=\"#edn38\"><span id=\"lblReferenceNo\">38<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.biorxiv.org\/content\/10.1101\/2022.06.07.495116v1\" target=\"_blank\" rel=\"noopener\">bioRxiv June 7, 2022<\/a><\/li>\n<li><sup><span id=\"ednref39\" data-hash=\"#edn39\"><span id=\"lblReferenceNo\">39<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.revyuh.com\/top-news\/featured\/as-paxlovid-fails-experts-question-another-covid-19-anti-viral-pill-its-completely-not-worth-it\/\" target=\"_blank\" rel=\"noopener\">Revyuh May 1, 2022<\/a><\/li>\n<li><sup><span id=\"ednref40\" data-hash=\"#edn40\"><span id=\"lblReferenceNo\">40<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.fiercepharma.com\/pharma\/pfizer-to-exceed-100b-revenue-2022-thanks-to-covid-19-drug-and-vaccine-analyst\" target=\"_blank\" rel=\"noopener\">Fierce Pharma November 21, 2021<\/a><\/li>\n<li><sup><span id=\"ednref41\" data-hash=\"#edn41\"><span id=\"lblReferenceNo\">41<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/khn.org\/news\/article\/pfizer-pandemic-vaccine-market-paxlovid-outsize-profit-influence\/\" target=\"_blank\" rel=\"noopener\">KHN July 5, 2022<\/a><\/li>\n<li><sup><span id=\"ednref42\" data-hash=\"#edn42\"><span id=\"lblReferenceNo\">42<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer_appoints_mikael_dolsten_president_of_worldwide_research_and_development\" target=\"_blank\" rel=\"noopener\">Pfizer May 25, 2010<\/a><\/li>\n<li><sup><span id=\"ednref43\" data-hash=\"#edn43\"><span id=\"lblReferenceNo\">43<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.fda.gov\/about-fda\/what-we-do\" target=\"_blank\" rel=\"noopener\">FDA Mission<\/a><\/li>\n<li><sup><span id=\"ednref44\" data-hash=\"#edn44\"><span id=\"lblReferenceNo\">44<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.cdc.gov\/about\/organization\/mission.htm\" target=\"_blank\" rel=\"noopener\">CDC Mission<\/a><\/li>\n<li><sup><span id=\"ednref45\" data-hash=\"#edn45\"><span id=\"lblReferenceNo\">45<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.ajmc.com\/view\/gilead-sciences-sets-us-price-for-covid19-drug-at-2340-to-3120-based-on-insurance\" target=\"_blank\" rel=\"noopener\">AJMC June 29, 2020<\/a><\/li>\n<li><sup><span id=\"ednref46\" data-hash=\"#edn46\"><span id=\"lblReferenceNo\">46<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/arxiv.org\/abs\/2201.08176v1\" target=\"_blank\" rel=\"noopener\">Cornell University, January 20, 2022<\/a><\/li>\n<li><sup><span id=\"ednref47\" data-hash=\"#edn47\"><span id=\"lblReferenceNo\">47<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.wellrx.com\/prescriptions\/ivermectin\/\" target=\"_blank\" rel=\"noopener\">WellRx, Ivermectin<\/a><\/li>\n<li><sup><span id=\"ednref48\" data-hash=\"#edn48\"><span id=\"lblReferenceNo\">48<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.drugs.com\/price-guide\/ivermectin\" target=\"_blank\" rel=\"noopener\">Drugs.com Ivermectin<\/a><\/li>\n<li><sup><span id=\"ednref49\" data-hash=\"#edn49\"><span id=\"lblReferenceNo\">49<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2788253\" target=\"_blank\" rel=\"noopener\">JAMA 2022;327(6):584-587<\/a><\/li>\n<li><sup><span id=\"ednref50\" data-hash=\"#edn50\"><span id=\"lblReferenceNo\">50<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.precisionvaccinations.com\/2021\/11\/18\/pfizers-covid-19-oral-antiviral-cost-529-course\" target=\"_blank\" rel=\"noopener\">Precision Vaccinations, November 19, 2021<\/a><\/li>\n<li><sup><span id=\"ednref51\" data-hash=\"#edn51\"><span id=\"lblReferenceNo\">51<\/span><\/span><\/sup>\u00a0<a id=\"lnkReference\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/price-covid-treatments-pfizer-merck-gsk-align-with-patient-benefits-report-2022-02-03\/\" target=\"_blank\" rel=\"noopener\">Reuters February 3, 2022<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<p>___<br \/>\n<a href=\"https:\/\/articles.mercola.com\/sites\/articles\/archive\/2022\/11\/10\/paxlovid-fraud.aspx?ui=7d4f35cff736f077b2ae4301813d0195449985379d483f57b37156f601517996&sd=20190616&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20221108_HL2&cid=DM1282559&bid=1639965512\">https:\/\/articles.mercola.com\/sites\/articles\/archive\/2022\/11\/10\/paxlovid-fraud.aspx?ui=7d4f35cff736f077b2ae4301813d0195449985379d483f57b37156f601517996&sd=20190616&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20221108_HL2&cid=DM1282559&bid=1639965512<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analysis by Dr. Joseph Mercola<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-143891","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/143891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=143891"}],"version-history":[{"count":0,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/143891\/revisions"}],"wp:attachment":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=143891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=143891"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=143891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}